Rebecca A. Juliano, Ph.D.
Affiliations: | 2004 | Columbia University, New York, NY |
Area:
Nutrition, General BiophysicsGoogle:
"Rebecca Juliano"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Richard Deckelbaum | grad student | 2004 | Columbia | |
| (The interplay of free fatty acids and cholesterol through membranes and SREBP: A study of physical and cellular systems.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sherratt SCR, Juliano RA, Mason RP. (2020) Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro. Biochimica Et Biophysica Acta. Biomembranes. 183254 |
| Miller M, Ballantyne CM, Bays HE, et al. (2019) Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study). The American Journal of Cardiology |
| Ballantyne CM, Manku MS, Bays HE, et al. (2019) Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study. Cardiology and Therapy |
| Ballantyne CM, Bays HE, Philip S, et al. (2016) Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies. Atherosclerosis. 253: 81-87 |
| Ballantyne CM, Bays HE, Braeckman RA, et al. (2016) Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies. Journal of Clinical Lipidology. 10: 635-645.e1 |
| Bays HE, Ballantyne CM, Braeckman RA, et al. (2015) Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 13: 239-47 |
| Worgall TS, Juliano RA, Seo T, et al. (2004) Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 943-8 |
| Worgall TS, Davis-Hayman SR, Magana MM, et al. (2004) Sterol and fatty acid regulatory pathways in a Giardia lamblia-derived promoter: evidence for SREBP as an ancient transcription factor. Journal of Lipid Research. 45: 981-8 |
| Juliano RA, Deckelbaum RJ, Worgall TS. (2004) Fatty acids, cholesterol, and sphingolipids: interactive regulators and targets for SREBP processing International Congress Series. 1262: 55-58 |
| Deckelbaum R, Juliano R, Worgall T. (2003) 1SY01-3 Fatty acids, cholesterol, and sphingolipids: Interactive regulators and targets for SREBP processing Atherosclerosis Supplements. 4: 3 |